|
CALL
|
$714,000
|
38K
|
Q2 2025
Reduced 42.32%
|
|
|
PUT
|
$289,000
|
15.4K
|
Q2 2025
Reduced 42.32%
|
|
|
CALL
|
$777,000
|
11K
|
Q2 2025
Reduced 43.27%
|
|
|
PUT
|
$417,000
|
5.9K
|
Q2 2025
Reduced 43.27%
|
|
|
PUT
|
$200,000
|
5.5K
|
Q2 2025
New holding
|
|
|
CALL
|
$862,000
|
37K
|
Q2 2025
Added 23.02%
|
|
|
PUT
|
$759,000
|
32.6K
|
Q2 2025
Added 23.02%
|
|
|
CALL
|
$171,000
|
24.4K
|
Q2 2025
Added 62.67%
|
|
|
CALL
|
$289,000
|
7.1K
|
Q2 2025
Added 5.97%
|
|
|
CALL
|
$1.57 Million
|
43.1K
|
Q2 2025
Reduced 29.26%
|
|
|
PUT
|
$1.66 Million
|
45.7K
|
Q2 2025
Reduced 29.26%
|
|
|
CALL
|
$318,000
|
14.1K
|
Q2 2025
New holding
|
|
|
CALL
|
$218,000
|
6K
|
Q2 2025
Added 14.75%
|
|
|
PUT
|
$509,000
|
14K
|
Q2 2025
Added 14.75%
|
|
|
CALL
|
$1.98 Million
|
42.3K
|
Q2 2025
New holding
|
|
|
PUT
|
$608,000
|
13K
|
Q2 2025
New holding
|
|
|
CALL
|
$1.66 Million
|
127K
|
Q2 2025
Reduced 67.42%
|
|
|
PUT
|
$712,000
|
54.6K
|
Q2 2025
Reduced 67.42%
|
|
|
CALL
|
$499,000
|
21.1K
|
Q2 2025
New holding
|
|
|
PUT
|
$371,000
|
15.7K
|
Q2 2025
New holding
|
|
|
PUT
|
$85,000
|
12.2K
|
Q2 2025
Added 16.19%
|
|
|
CALL
|
$272,000
|
10.6K
|
Q2 2025
New holding
|
|
|
CALL
|
$0
|
54.7K
|
Q2 2025
Added 31.18%
|
|
|
CALL
|
$4.74 Million
|
8K
|
Q2 2025
Reduced 44.44%
|
|
|
PUT
|
$1.48 Million
|
2.5K
|
Q2 2025
Reduced 44.44%
|
|
|
CALL
|
$608,000
|
11K
|
Q2 2025
Reduced 15.62%
|
|
|
PUT
|
$2.3 Million
|
41.6K
|
Q2 2025
Reduced 15.62%
|
|
|
CALL
|
$59,000
|
12.4K
|
Q2 2025
New holding
|
|
|
CALL
|
$439,000
|
5.8K
|
Q2 2025
Reduced 54.69%
|
|
|
CALL
|
$1.43 Million
|
288K
|
Q2 2025
Added 0.71%
|
|
|
PUT
|
$210,000
|
42.6K
|
Q2 2025
Added 0.71%
|
|
|
CALL
|
$0
|
15.4K
|
Q2 2025
Added 41.28%
|
|
|
CALL
|
$607,000
|
113K
|
Q2 2025
Reduced 19.05%
|
|
|
PUT
|
$451,000
|
83.7K
|
Q2 2025
Reduced 19.05%
|
|
|
CALL
|
$621,000
|
900
|
Q2 2025
New holding
|
|
|
PUT
|
$1.04 Million
|
1.5K
|
Q2 2025
New holding
|
|
|
CALL
|
$247,000
|
8.5K
|
Q2 2025
New holding
|
|
|
PUT
|
$604,000
|
20.8K
|
Q2 2025
New holding
|
|
Neumora Therapeutics Inc.
|
CALL
|
$0
|
12.1K
|
Q2 2025
New holding
|
|
Neumora Therapeutics Inc.
|
PUT
|
$0
|
10.7K
|
Q2 2025
New holding
|
|
|
CALL
|
$904,000
|
7.2K
|
Q2 2025
New holding
|
|
|
CALL
|
$64,000
|
13.5K
|
Q2 2025
New holding
|
|
|
CALL
|
$183,000
|
13K
|
Q2 2025
Reduced 21.26%
|
|
|
PUT
|
$334,000
|
23.7K
|
Q2 2025
Reduced 21.26%
|
|
|
CALL
|
$2.91 Million
|
445K
|
Q2 2025
Added 380.99%
|
|
|
PUT
|
$1.08 Million
|
165K
|
Q2 2025
Added 380.99%
|
|
|
CALL
|
$391,000
|
14K
|
Q2 2025
New holding
|
|
|
CALL
|
$1.33 Million
|
59.2K
|
Q2 2025
Added 74.14%
|
|
|
PUT
|
$909,000
|
40.4K
|
Q2 2025
Added 74.14%
|
|
|
CALL
|
$2.4 Million
|
5.9K
|
Q2 2025
Reduced 82.22%
|
|